NCT03848351

Brief Summary

The purpose of the study is to evaluate the impact of oral hygiene changes (drastic plaque and gingival inflammation reduction) on markers of systemic inflammation and indicators of oral health related quality of life and other aspects related to overall well-being. The primary objective is to assess a possible reduction of systemic inflammation as measured through blood bio-markers one month after drastic changes of plaque accumulation. As primary outcome measure, the level of high-sensitive C-reactive protein (hs-CRP) will be assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 20, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 4, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 4, 2021

Completed
Last Updated

November 7, 2022

Status Verified

November 1, 2022

Enrollment Period

2.1 years

First QC Date

February 15, 2019

Last Update Submit

November 2, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline of High sensitivity C-Reactive Protein (hsCRP) at 1 month

    analyzed though blood sampling. Unit of measure: mg/L

    Difference of values of the markers collected at Baseline and 1 month after treatment

Secondary Outcomes (12)

  • Change from baseline of Interleukin 6 at 1 month

    Difference of values of the markers collected at Baseline and 1 month after treatment

  • Vitamin D

    Collected at Baseline

  • Full-mouth plaque score (FMPS)

    Measured at Baseline and 1 month after treatment

  • Full-mouth bleeding score (FMBS)

    Measured at Baseline and 1 month after treatment

  • Pocket probing depth (PPD)

    Measured at Baseline and 1 month after treatment

  • +7 more secondary outcomes

Study Arms (2)

Control Group

NO INTERVENTION

70 patients not receiving oral hygiene instructions or devices and continuing with their routine oral hygiene habits

Test Group

ACTIVE COMPARATOR

70 patients receiving intense oral hygiene instructions assisted by specific software or devices as well as oral hygiene (OH) tools (electric toothbrush, interdental floss, toothpaste) Thus, interventions will consist of. * Oral Hygiene Instruction (OHI) * Professional supragingival scaling and polishing

Behavioral: Oral Hygiene Instruction (OHI)Procedure: Professional supragingival scaling and polishing

Interventions

OHI will be given focusing on electric toothbrushing as first instance and subsequently focusing on interdental cleaning. OHI will be delivered by trained dental hygienist/periodontist. In the first phase the clinician will explain and show the technique to the patient. The patient will be then invited to perform the technique. Each phase will be assisted and monitored by the clinician. Overall, this sequence may be repeated as many times as the clinician would deem appropriate.

Test Group

Patients will receive a session of professional supragingival scaling and polishing, that consists of removal of dental plaque and dental calculus from the surface of a tooth, with great care in performing exclusively coronal maneuver. No instrumentation or exploring of the gingival crevice/ sulcus will be performed. Instrumentation will be performed by a trained dental hygienist/periodontist.

Test Group

Eligibility Criteria

Age18 Years - 79 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • male or female, 18 to 79 of age, of any race/ethnicity;
  • presence of at least 20 teeth;
  • ≤ 2 untreated dental caries;
  • presence of relevant plaque accumulation as shown by Full Mouth Plaque Scores (FMBS) \>50%.
  • presence of relevant periodontal/gingival inflammation as shown by FMBS \> 35%

You may not qualify if:

  • pregnancy and breast feeding;
  • patients undergoing pharmacological treatment capable of reducing CRP such as statins or chronic anti-inflammatory treatment,
  • current or past (≤ 30 days) systemic or local antibiotic therapy;
  • heavy smokers (over 20 cigarettes per day or pipe or cigar);
  • patients undergoing orthodontic treatment;
  • patients not capable to comply with given instruction or administrative issues related to the study
  • dental or periodontal conditions (e.g., deep caries, periodontal abscess) requiring urgent treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Pisa

Pisa, 56126, Italy

Location

Related Publications (1)

  • Peric M, Marhl U, Gennai S, Marruganti C, Graziani F. Treatment of gingivitis is associated with reduction of systemic inflammation and improvement of oral health-related quality of life: A randomized clinical trial. J Clin Periodontol. 2022 Sep;49(9):899-910. doi: 10.1111/jcpe.13690. Epub 2022 Jul 17.

MeSH Terms

Conditions

Gingivitis

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Outcome assessor will not be present during explanation of oral hygiene maneuvers. Moreover, participants will be asked not to mention about techniques and group participation to the outcome assessors.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Single-centre randomized, parallel design, clinical trial with a 1-month follow-up
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor of Dentistry

Study Record Dates

First Submitted

February 15, 2019

First Posted

February 20, 2019

Study Start

April 1, 2019

Primary Completion

May 4, 2021

Study Completion

May 4, 2021

Last Updated

November 7, 2022

Record last verified: 2022-11

Locations